Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN43635237
ISRCTN43635237
Completed
Not Applicable

acetylcysteine as a Preventive Measure for Contrast Induced Nephropathy in Intensive Care Patients with Renal Insufficiency

Academic Medical Centre (AMC) (Netherlands)0 sites246 target enrollmentDecember 20, 2005
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsRenal insufficiencyUrological and Genital Diseases

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Renal insufficiency
Sponsor
Academic Medical Centre (AMC) (Netherlands)
Enrollment
246
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 20, 2005
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional

Investigators

Sponsor
Academic Medical Centre (AMC) (Netherlands)

Eligibility Criteria

Inclusion Criteria

  • •1\. (Chronic or acute) renal insufficiency (not presently on renal replacement therapy) defined as a plasma creatinine greater than 180 µmol/L
  • •2\. Planned diagnostic imaging procedure requiring the use of intravenous radiographic contrast agents
  • •3\. Admitted to one of the participating intensive care units

Exclusion Criteria

  • •1\. Pregnancy
  • •2\. No informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
se of N-Acetylcysteine for prevention of Heart-Lung machine associated liver complication in cardiac surgery
CTRI/2018/05/014024Dr Ram Manohar Lohia institute of Medical Sciences Lucknow66
Active, not recruiting
Not Applicable
Acetytilcysteine Versus placebo for the prevention of Acute Reduction in Renal function after primary Angioplasty (NoVARA) - NoVARApatient with ST elevation myocardial acute infarctionMedDRA version: 9.1Level: SOCClassification code 10007541
EUCTR2010-022952-22-ITAZIENDA OSPEDALIERA MAGGIORE DELLA CARITA` DI NOVARA
Completed
Phase 2
Adjuvant N Acetylcysteine for Post Traumatuic Stress Disorder
ACTRN12618001784202Austin Health105
Completed
Not Applicable
Effect of N - Acetylcysteine in the prevention of ototoxicity caused by vancomycin.Peritonitis.Peritonitis, unspecified
IRCT201202148032N2Research Assistance Of Tabriz University Of Medical Science60
Completed
Not Applicable
The use of perioperative n-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypassCoronary artery bypass graft surgeryCirculatory System
ISRCTN94451985The Physician Services Incorporated Foundation (Canada)295